$219.24
1.02% today
NYSE, Apr 03, 06:46 pm CET
ISIN
US9553061055
Symbol
WST

West Pharmaceutical Services, Inc. Stock price

$221.50
-6.55 2.87% 1M
-78.31 26.12% 6M
-106.06 32.38% YTD
-166.40 42.90% 1Y
-187.53 45.85% 3Y
+65.82 42.28% 5Y
+164.82 290.79% 10Y
NYSE, Closing price Wed, Apr 02 2025
+1.34 0.61%
ISIN
US9553061055
Symbol
WST
Sector

Key metrics

Market capitalization $16.01b
Enterprise Value $15.83b
P/E (TTM) P/E ratio 33.11
EV/FCF (TTM) EV/FCF 57.28
EV/Sales (TTM) EV/Sales 5.47
P/S ratio (TTM) P/S ratio 5.54
P/B ratio (TTM) P/B ratio 5.97
Dividend yield 0.37%
Last dividend (FY24) $0.82
Revenue growth (TTM) Revenue growth -1.93%
Revenue (TTM) Revenue $2.89b
EBIT (operating result TTM) EBIT $596.20m
Free Cash Flow (TTM) Free Cash Flow $276.40m
Cash position $484.60m
EPS (TTM) EPS $6.69
P/E forward 36.77
P/S forward 5.54
EV/Sales forward 5.48
Short interest 2.80%
Show more

Is West Pharmaceutical Services, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

West Pharmaceutical Services, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

11x Buy
73%
4x Hold
27%

Analyst Opinions

15 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

Buy
73%
Hold
27%

Financial data from West Pharmaceutical Services, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,893 2,893
2% 2%
100%
- Direct Costs 1,891 1,891
4% 4%
65%
1,002 1,002
11% 11%
35%
- Selling and Administrative Expenses 182 182
13% 13%
6%
- Research and Development Expense 69 69
1% 1%
2%
752 752
12% 12%
26%
- Depreciation and Amortization 155 155
13% 13%
5%
EBIT (Operating Income) EBIT 596 596
17% 17%
21%
Net Profit 493 493
17% 17%
17%

In millions USD.

Don't miss a Thing! We will send you all news about West Pharmaceutical Services, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

West Pharmaceutical Services, Inc. Stock News

Positive
Seeking Alpha
3 days ago
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Brown (+20.65%), and AbbVie (+16.61%), showcasing strong double-digit gains. 29 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.15%.
Positive
Seeking Alpha
20 days ago
Four of the ten lowest-priced Dividend Aristocrats, including Franklin Resources and Realty Income, are ready to buy with annual dividends exceeding their single share prices. Analysts forecast 15.93% to 26.49% net gains for top-ten Aristocrat Dogs by March 2026, with Federal Realty and Stanley Black & Decker leading. A market correction of 65% could make all top-yield Aristocrats fair-priced, ...
Neutral
Seeking Alpha
24 days ago
West Pharmaceutical Services has faced a challenging year, underperforming against the index, with declining volumes, margins, and returns, but remains a strong long-term investment. The company's high-value products segment, driven by GLP-1 medications and biologics, is expected to boost margins and returns significantly. Despite poor timing in share buybacks and management concerns, West's va...
More West Pharmaceutical Services, Inc. News

Company Profile

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Head office United States
CEO Eric Green
Employees 10,600
Founded 1923
Website www.westpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today